495 related articles for article (PubMed ID: 25550115)
1. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
Zhang E; Lu M
Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
4. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.
Pei RJ; Chen XW; Lu MJ
World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
7. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication].
Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
Front Immunol; 2022; 13():965018. PubMed ID: 35967443
[TBL] [Abstract][Full Text] [Related]
9. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
Chang J; Block TM; Guo JT
Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
[TBL] [Abstract][Full Text] [Related]
10. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.
Jiang X; Kanda T; Wu S; Nakamura M; Miyamura T; Nakamoto S; Banerjee A; Yokosuka O
World J Gastroenterol; 2014 Jun; 20(23):7197-206. PubMed ID: 24966589
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
Isogawa M; Robek MD; Furuichi Y; Chisari FV
J Virol; 2005 Jun; 79(11):7269-72. PubMed ID: 15890966
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.
Soleiman-Meigooni S; Yarahmadi A; Kheirkhah AH; Afkhami H
Front Immunol; 2024; 15():1363996. PubMed ID: 38545106
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
Ma Z; Cao Q; Xiong Y; Zhang E; Lu M
Vaccines (Basel); 2018 Jan; 6(1):. PubMed ID: 29337856
[TBL] [Abstract][Full Text] [Related]
14. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
[TBL] [Abstract][Full Text] [Related]
15. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri.
Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K
Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415
[TBL] [Abstract][Full Text] [Related]
16. The IL-1R/TLR signaling pathway is essential for efficient CD8
Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M
Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610
[TBL] [Abstract][Full Text] [Related]
17. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
Front Immunol; 2021; 12():684424. PubMed ID: 34113355
[TBL] [Abstract][Full Text] [Related]
18. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen.
Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R
Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087
[TBL] [Abstract][Full Text] [Related]
20. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D
Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
